RUNX3 and p53: How two tumor suppressors cooperate against oncogenic ras?

Jung Won Lee, Andre J van Wijnen, Suk Chul Bae

Research output: Chapter in Book/Report/Conference proceedingChapter

4 Scopus citations

Abstract

RUNX family members play pivotal roles in both normal development and neoplasia. In particular, RUNX1 and RUNX2 are essential for determination of the hematopoietic and osteogenic lineages, respectively. RUNX3 is involved in lineage determination of various types of epithelial cells. Analysis of mouse models and human cancer specimens revealed that RUNX3 acts as a tumor suppressor via multiple mechanisms. p53-related pathways play central roles in tumor suppression through the DNA damage response and oncogene surveillance, and RUNX3 is involved in both processes. In response to DNA damage, RUNX3 facilitates p53 phosphorylation by the ATM/ATR pathway and p53 acetylation by p300. When oncogenes are activated, RUNX3 induces ARF, thereby stabilizing p53. Here, we summarize the molecular mechanisms underlying the p53-mediated tumor-suppressor activity of RUNX3.

Original languageEnglish (US)
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York LLC
Pages321-332
Number of pages12
Volume962
DOIs
StatePublished - 2017

Publication series

NameAdvances in Experimental Medicine and Biology
Volume962
ISSN (Print)00652598
ISSN (Electronic)22148019

Keywords

  • ARF
  • DNA damage
  • Oncogene surveillance
  • p53
  • RUNX
  • Tumor suppressor

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'RUNX3 and p53: How two tumor suppressors cooperate against oncogenic ras?'. Together they form a unique fingerprint.

  • Cite this

    Lee, J. W., van Wijnen, A. J., & Bae, S. C. (2017). RUNX3 and p53: How two tumor suppressors cooperate against oncogenic ras? In Advances in Experimental Medicine and Biology (Vol. 962, pp. 321-332). (Advances in Experimental Medicine and Biology; Vol. 962). Springer New York LLC. https://doi.org/10.1007/978-981-10-3233-2_20